These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3490657)

  • 1. Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey.
    Udelsman R; Gallucci WT; Bacher J; Loriaux DL; Chrousos GP
    Peptides; 1986; 7(3):465-71. PubMed ID: 3490657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and endocrine parameters in the anesthetized cynomolgus monkey: a primate model.
    Udelsman R; Bacher J; Gallucci WT; Gold PW; Morin ML; Renquist D; Loriaux DL; Chrousos GP
    J Med Primatol; 1984; 13(6):327-38. PubMed ID: 6097691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human corticotropin-releasing hormone in man: dose-response of minute ventilation and end-tidal partial pressures of carbon dioxide and oxygen.
    Oppermann D; Huber I; Nink M; Schulz V
    J Clin Endocrinol Metab; 1987 Feb; 64(2):292-6. PubMed ID: 3098772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associated endocrine, physiological and behavioral changes in rhesus monkeys after intravenous corticotropin-releasing factor administration.
    Kalin NH; Shelton SE; Kraemer GW; McKinney WT
    Peptides; 1983; 4(2):211-5. PubMed ID: 6312433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory action of corticotropin-releasing hormone on gonadotropin secretion in the ovariectomized rhesus monkey is not mediated by adrenocorticotropic hormone.
    Xiao EN; Ferin M
    Biol Reprod; 1988 May; 38(4):763-7. PubMed ID: 2840981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man.
    Kellner M; Wiedemann K; Holsboer F
    Life Sci; 1992; 50(24):1835-42. PubMed ID: 1317939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam.
    Rohrer T; von Richthofen V; Schulz C; Beyer J; Lehnert H
    Horm Metab Res; 1994 Apr; 26(4):200-6. PubMed ID: 8082875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses.
    Davis ME; Pemberton CJ; Yandle TG; Fisher SF; Lainchbury JG; Frampton CM; Rademaker MT; Richards AM
    J Am Coll Cardiol; 2007 Jan; 49(4):461-71. PubMed ID: 17258092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.
    Rademaker MT; Charles CJ; Espiner EA; Fisher S; Frampton CM; Kirkpatrick CM; Lainchbury JG; Nicholls MG; Richards AM; Vale WW
    J Am Coll Cardiol; 2002 Oct; 40(8):1495-505. PubMed ID: 12392842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blunted cortisol response after administration of corticotropin releasing hormone in endotoxemic dogs.
    Moeniralam HS; Endert E; van Lanschot JJ; Sauerwein HP; Romijn JA
    J Endocrinol Invest; 1997 Sep; 20(8):476-81. PubMed ID: 9364251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral administration of human corticotropin-releasing hormone: a novel method to increase energy expenditure and fat oxidation in man.
    Smith SR; de Jonge L; Pellymounter M; Nguyen T; Harris R; York D; Redmann S; Rood J; Bray GA
    J Clin Endocrinol Metab; 2001 May; 86(5):1991-8. PubMed ID: 11344197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and pharmacokinetic properties of the rat/human corticotropin-releasing factor in rhesus monkeys.
    Schürmeyer TH; Gold PW; Gallucci WT; Tomai TP; Cutler GB; Loriaux DL; Chrousos GP
    Endocrinology; 1985 Jul; 117(1):300-6. PubMed ID: 2988919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses to exogenous dibutyryl adenosine 3',5'-monophosphate of cardiac output and blood flow in the renal, superior mesenteric and carotid arteries in anesthetized dogs.
    Nozaki H; Okuaki A
    Tohoku J Exp Med; 1975 Feb; 115(2):145-54. PubMed ID: 165589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs.
    Higashio T; Tsuji Y; Nakao K; Sakaguchi S; Tanaka M
    Arzneimittelforschung; 1988 Mar; 38(3):350-8. PubMed ID: 3382459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors and actions of corticotropin-releasing hormone in the primate pituitary gland.
    Millan MA; Samra AB; Wynn PC; Catt KJ; Aguilera G
    J Clin Endocrinol Metab; 1987 May; 64(5):1036-41. PubMed ID: 3031117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.